Title |
Under one roof: identification, evaluation, and treatment of chronic hepatitis C in addiction care
|
---|---|
Published in |
Addiction Science & Clinical Practice, April 2018
|
DOI | 10.1186/s13722-018-0111-7 |
Pubmed ID | |
Authors |
Stephen A. Martin, Jordon Bosse, Amanda Wilson, Phyllis Losikoff, Lisa Chiodo |
Abstract |
For over a decade, the vast majority of new hepatitis C virus (HCV) infections have been among young people who inject drugs (PWID). Well-characterized gaps in chronic HCV diagnosis, evaluation, and treatment have resulted in fewer than 5% of PWID receiving HCV treatment. While interferon-based treatment may have intentionally been foregone during part of this time in anticipation of improved oral therapies, the overall pattern points to deficiencies and treatment exclusions in the health care system. Treatment for HCV with all-oral, highly effective direct-acting antiviral medication for 12 weeks or less is now the standard of care, putting renewed focus on effective delivery of care. We describe here both the need for and process of chronic HCV care under the roof of addiction medicine. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 3 | 50% |
Canada | 1 | 17% |
Unknown | 2 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 5 | 83% |
Scientists | 1 | 17% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 39 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 9 | 23% |
Student > Bachelor | 3 | 8% |
Other | 3 | 8% |
Researcher | 3 | 8% |
Student > Doctoral Student | 2 | 5% |
Other | 4 | 10% |
Unknown | 15 | 38% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 6 | 15% |
Neuroscience | 3 | 8% |
Agricultural and Biological Sciences | 3 | 8% |
Biochemistry, Genetics and Molecular Biology | 2 | 5% |
Nursing and Health Professions | 1 | 3% |
Other | 6 | 15% |
Unknown | 18 | 46% |